Abstract
Colon delivery is especially required for drugs intended to act locally or for drugs that exhibit maximum systemic absorption from the colon. However, exposure to extreme pH conditions, gastric enzymes, bile salts and variation in gastric emptying makes the development of colon release dosage forms extremely challenging. The approaches generally used for formulating a colon release dosage form include use of pH dependent release polymers, time-release coatings, prodrugs and biodegradable polymers. Although, considerable choice exists while selecting a pH dependent release polymer, the drug release from these polymers is easily influenced by nature of diet and disease. In addition, while these polymers may prevent drug release in stomach (pH 1-3) and proximal small intestine (pH 6.5), the drug may be prematurely released in vivo in lower small intestine (pH 7.5). Similarly, variation in gastric transit time due to nature of diet and severity of disease often lead to reduced performance of time-release based colon delivery dosage forms. Therefore, new approaches are continuously being evaluated to ensure compliance with requirement of colon release and to reduce the variation in their performance. This article is aimed at studying the recent patents with a view to unveil new concepts being put into use for designing colon release dosage forms.
Keywords: Colon drug delivery, colon targeting, microbially triggered delivery system, pH dependent drug delivery, polysaccharidic matrix oral formulations, biodegradable polymer based colon drug delivery
Recent Patents on Drug Delivery & Formulation
Title: Recent Approaches for Colon Drug Delivery
Volume: 1 Issue: 3
Author(s): Gurpreet Kaur, Subheet Jain and Ashok K. Tiwary
Affiliation:
Keywords: Colon drug delivery, colon targeting, microbially triggered delivery system, pH dependent drug delivery, polysaccharidic matrix oral formulations, biodegradable polymer based colon drug delivery
Abstract: Colon delivery is especially required for drugs intended to act locally or for drugs that exhibit maximum systemic absorption from the colon. However, exposure to extreme pH conditions, gastric enzymes, bile salts and variation in gastric emptying makes the development of colon release dosage forms extremely challenging. The approaches generally used for formulating a colon release dosage form include use of pH dependent release polymers, time-release coatings, prodrugs and biodegradable polymers. Although, considerable choice exists while selecting a pH dependent release polymer, the drug release from these polymers is easily influenced by nature of diet and disease. In addition, while these polymers may prevent drug release in stomach (pH 1-3) and proximal small intestine (pH 6.5), the drug may be prematurely released in vivo in lower small intestine (pH 7.5). Similarly, variation in gastric transit time due to nature of diet and severity of disease often lead to reduced performance of time-release based colon delivery dosage forms. Therefore, new approaches are continuously being evaluated to ensure compliance with requirement of colon release and to reduce the variation in their performance. This article is aimed at studying the recent patents with a view to unveil new concepts being put into use for designing colon release dosage forms.
Export Options
About this article
Cite this article as:
Kaur Gurpreet, Jain Subheet and Tiwary K. Ashok, Recent Approaches for Colon Drug Delivery, Recent Patents on Drug Delivery & Formulation 2007; 1 (3) . https://dx.doi.org/10.2174/187221107782331665
DOI https://dx.doi.org/10.2174/187221107782331665 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
Related Articles
-
MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Current Alzheimer Research Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics Editorial : Meet Our Editorial Board Member
Current Nutrition & Food Science Primary and Secondary Hypertriglyceridaemia
Current Drug Targets Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Simvastatin: Review of Updates on Recent Trends in Pharmacokinetics, Pharmacodynamics, Drug–drug Interaction, Impurities and Analytical Methods
Current Pharmaceutical Analysis Importance of Dietary Supplements to the Health
Current Nutrition & Food Science The Role of the Calcium-Sensing Receptor in Human Pathophysiology
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Adult Mesenchymal Stem Cells: A Pluripotent Population with Multiple Applications
Current Stem Cell Research & Therapy Marine Collagen as a Source of Bioactive Molecules: A Review
The Natural Products Journal Potential Application of Plant-derived Bioengineered Human VEGF for Tissue Regeneration
Current Pharmaceutical Biotechnology New Prospects for Nelfinavir in Non-HIV-Related Diseases
Current Molecular Pharmacology Cartilage Regeneration Using Adipose-Derived Stem Cells
Current Stem Cell Research & Therapy Effect of Human Platelet Lysate in Differentiation of Wharton’s Jelly Derived Mesenchymal Stem Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Renal Biopsy Research with Implications for Therapy of Glomerulonephritis
Current Drug Therapy Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets Antibacterial Function of the Human Cathelicidin-18 Peptide (LL-37) between Theory and Practice
Protein & Peptide Letters Yeast Network and Report of New Stochastic-Credibility Cell Cycle Models
Current Bioinformatics Aspartame: Should Individuals with Type II Diabetes be Taking it?
Current Diabetes Reviews Mutation, Selection and the Amino Acid Hydropathic Character: A Study on Receptor Genes Involved in Immune and Non-Immune Functions
Endocrine, Metabolic & Immune Disorders - Drug Targets